Covovax To Be Included On CoWIN As Heterologous Booster Dose For Adults

The Serum Institute of India (SII) has requested the inclusion of its COVID-19 vaccine, Covovax, on the CoWIN portal as a heterologous booster dose for adults in light of rising coronavirus cases.

Supported by

The Serum Institute of India (SII) has requested the inclusion of its COVID-19 vaccine, Covovax, on the CoWIN portal as a heterologous booster dose for adults in light of rising coronavirus cases, according to official sources.

The letter was composed by Prakash Kumar Singh, Chief, Serum Establishment of India (SII), on Walk 27, they said. As a heterologous booster dose for adults who have received two doses of either Covishield or Covaxin, the COVID-19 Working Group, led by Dr N K Arora, had also recommended that Covovax be added to the CoWIN portal last month. The same has been recommended to the health ministry by Covid-19 Working Group headed by Dr NK Arora had to include Covovax on the CoWin portal.

The Drugs Controller General of India (DCGI) approved Covovax’s market authorization for individuals who have received two doses of either Covishield or Covaxin. Additionally, both the US Food and Drug Administration (FDA) and the World Health Organization (WHO) have granted approval to Covovax, as per a report in The Indian Express.

World’s Largest Vaccine Manufacturer 

Covovax was approved by the DCGI for limited use in emergency situations on December 28, 2021, March 9, 2022, and June 28, 2022, subject to certain conditions, for adults, 12-17, and 7-11, respectively.

Novavax, a vaccine manufacturer based in the United States, transfers its technology to Covovax. The European Drugs Organization has supported it for contingent showcasing authorisation. On December 17, 2021, the WHO granted it an emergency-use listing.

Serum Institute of India is an Indian biotechnology and biopharmaceuticals company, based in Pune and it is the world’s largest manufacturer of vaccines. Founded by Cyrus Poonawalla in 1966, it is a part of Cyrus Poonawalla Group. Although CoWIN, Indian government web portal for COVID-19 vaccination registration, is owned and operated by India’s Ministry of Health and Family Welfare.

Also Read: Kerala University Plans To Become Completely Solar-Powered; Massive Savings Anticipated

https://thelogicalindian.com/h-upload/2023/04/04/500x300_230948-photo2023-04-0413-37-44.webp

Trending

2023-04-04 08:10:09.0

Covovax To Be Included On CoWIN As Heterologous Booster Dose For Adults

#PoweredByYou We bring you news and stories that are worth your attention! Stories that are relevant, reliable, contextual and unbiased. If you read us, watch us, and like what we do, then show us some love! Good journalism is expensive to produce and we have come this far only with your support. Keep encouraging independent media organisations and independent journalists. We always want to remain answerable to you and not to anyone else.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Amplified by

ITC Sunfeast - Mom's Magic

In a Season of Promotions, Sunfeast Mom’s Magic Shines with Purpose-Driven Will of Change Campaign

Amplified by

Mahindra

Nation Builders 2024 – Mahindra:  Forging a Resilient Future, Anchoring National Development

Recent Stories

Fire Erupts at Jungle Jamboree Restaurant in Delhi’s Rajouri Garden: Diners Jump Rooftops in Panic, One Injured

Sanjay Malhotra Appointed as New RBI Governor: What His Leadership Means for India’s Economy

Bihar’s Sex Ratio at Birth Hits a Shocking Low of 882: Government’s Swift Action Against Female Foeticide

Contributors

Writer : 
Editor : 
Creatives :